Published in Epidemiology on September 01, 1999
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87
Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ (2003) 2.99
Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr (2003) 2.80
The health impacts of exposure to indoor air pollution from solid fuels in developing countries: knowledge, gaps, and data needs. Environ Health Perspect (2002) 2.68
Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014. JAMA (2017) 2.63
How many deaths are caused by second hand cigarette smoke? Tob Control (2001) 2.07
Tobacco use or body mass--do they predict tuberculosis mortality in Mumbai, India? Results from a population-based cohort study. PLoS One (2012) 1.46
The burden of food related ill health in the UK. J Epidemiol Community Health (2005) 1.40
Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal (2012) 1.31
The evolution of the Global Burden of Disease framework for disease, injury and risk factor quantification: developing the evidence base for national, regional and global public health action. Global Health (2005) 1.25
Improvements In US Diet Helped Reduce Disease Burden And Lower Premature Deaths, 1999-2012; Overall Diet Remains Poor. Health Aff (Millwood) (2015) 1.22
Impact of a reduced red and processed meat dietary pattern on disease risks and greenhouse gas emissions in the UK: a modelling study. BMJ Open (2012) 1.10
Estimating the contribution of selected risk factors in attributable burden to stroke in iran. Iran J Public Health (2012) 1.05
The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol (2010) 1.04
Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure. Curr Neuropharmacol (2008) 1.00
Quitting smoking does not increase the risk of major depressive episodes among users of Internet smoking cessation interventions. Psychol Med (2009) 0.95
The contribution of leading diseases and risk factors to excess losses of healthy life in Eastern Europe: burden of disease study. BMC Public Health (2005) 0.94
Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model. J Virol (2002) 0.91
Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer (2011) 0.90
Estimating the proportion of diabetes to the attributable burden of cardiovascular diseases in iran. Iran J Public Health (2012) 0.89
Estimation of the regional burden of non-communicable diseases due to obesity and overweight in Markazi province, Iran, 2006-2007. J Cardiovasc Dis Res (2012) 0.88
Ideal cardiovascular health predicts functional status independently of vascular events: the Northern Manhattan Study. J Am Heart Assoc (2015) 0.86
Combining best evidence: a novel method to calculate the alcohol-attributable fraction and its variance for injury mortality. BMC Public Health (2011) 0.86
Measuring the health of populations: explaining composite indicators. J Public Health Res (2012) 0.84
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet (2017) 0.82
Developing a method to derive alcohol-attributable fractions for HIV/AIDS mortality based on alcohol's impact on adherence to antiretroviral medication. Popul Health Metr (2011) 0.81
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep (2016) 0.81
Gender differences in the association between pre-adolescent smoking initiation and emotional or behavioural problems. BMC Public Health (2010) 0.79
The effects of capping the alcohol consumption distribution and relative risk functions on the estimated number of deaths attributable to alcohol consumption in the European Union in 2004. BMC Med Res Methodol (2013) 0.79
Lean diesel technology and human health: a case study in six Brazilian metropolitan regions. Clinics (Sao Paulo) (2012) 0.79
A narrative review of alcohol consumption as a risk factor for global burden of disease. Subst Abuse Treat Prev Policy (2016) 0.78
Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview. BMC Public Health (2016) 0.78
Open-label, randomized, parallel-group controlled clinical trial of massage for treatment of depression in HIV-infected subjects. J Altern Complement Med (2012) 0.78
Common measures of disease burden, risk trade-offs, and improved environmental health decision-making. Epidemiology (2000) 0.78
Improving the estimation of the burden of risk factors: an illustrative comparison of methods to measure smoking-attributable mortality. Popul Health Metr (2015) 0.78
Residential radon and environmental burden of disease among Non-smokers. Ann Occup Environ Med (2016) 0.77
Joint effect of modifying selected risk factors on attributable burden of cardiovascular diseases. Int J Prev Med (2013) 0.77
Integrating the Demographic and Health Surveys, IPUMS-I, and TerraPopulus to Explore Mortality and Health Outcomes at the District Level in Ghana, Malawi, and Tanzania. Etude Popul Afr (2014) 0.77
Estimates of alcohol-related oesophageal cancer burden in Japan: systematic review and meta-analyses. Bull World Health Organ (2015) 0.77
The burden of blood-pressure-related cardiovascular mortality in Mexico. Int J Hypertens (2014) 0.76
Response to: Premature deaths attributed to ambient air pollutants: let us interpret the Robins-Greenland theorem correctly. Int J Public Health (2017) 0.75
Potentially preventable incidence of diabetes due to risk factor modification. J Diabetes Metab Disord (2012) 0.75
Beyond case fatality rate: using potential impact fraction to estimate the effect of increasing treatment uptake on mortality. BMC Med Res Methodol (2013) 0.75
Avoidable Burden of Risk Factors for Serious Road Traffic Crashes in Iran: A Modeling Study. J Prev Med Public Health (2017) 0.75
Association of alcohol consumption to mortality and person-years of life lost in Switzerland--measuring the impact of some methodological options. Eur J Epidemiol (2005) 0.75
Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. Eur Respir J (2017) 0.75
Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet (1997) 44.03
Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet (1997) 29.18
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet (1997) 25.40
Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet (1992) 25.28
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med (1997) 8.25
Mortality from smoking worldwide. Br Med Bull (1996) 7.87
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet (1997) 7.29
The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ (1994) 6.99
The global burden of disease, 1990-2020. Nat Med (1998) 6.50
Quantifying disability: data, methods and results. Bull World Health Organ (1994) 4.99
Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control (2003) 4.94
Armed conflict as a public health problem. BMJ (2002) 4.42
Healthy life expectancy in 191 countries, 1999. Lancet (2001) 4.31
The decline in child mortality: a reappraisal. Bull World Health Organ (2000) 3.46
Global and regional cause-of-death patterns in 1990. Bull World Health Organ (1994) 3.37
Progress and directions in refining the global burden of disease approach: a response to Williams. Health Econ (2000) 3.17
The use of cause-of-death statistics for health situation assessment: national and international experiences. World Health Stat Q (1990) 2.84
The utility of DALYs for public health policy and research: a reply. Bull World Health Organ (1997) 2.49
Regional, disease specific patterns of smoking-attributable mortality in 2000. Tob Control (2004) 2.12
Measuring the burden of disease. Lancet (1998) 1.58
At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer (1994) 1.45
Hypertension in developing countries. World Health Stat Q (1988) 1.45
Sustained proliferation of PDX-1+ cells derived from human islets. Diabetes (1999) 1.35
Ex vivo expansion of human pancreatic endocrine cells. J Clin Endocrinol Metab (1997) 1.33
Tobacco or health. World Health Stat Q (1993) 1.32
KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development. J Cell Biol (1998) 1.26
Global and regional mortality patterns by cause of death in 1980. Int J Epidemiol (1986) 1.22
Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia (2007) 1.21
An in vivo model for study of the angiogenic effects of basic fibroblast growth factor. Biochem Biophys Res Commun (1987) 1.19
Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol (2000) 1.18
Counting the dead in China. Measuring tobacco's impact in the developing world. BMJ (1998) 1.14
Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes (1995) 1.13
The incremental effect of age-weighting on YLLs, YLDs, and DALYs: a response. Bull World Health Organ (1996) 1.09
Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes (1994) 1.08
On the assessment of maternal mortality. World Health Stat Q (1987) 1.04
A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J Clin Endocrinol Metab (2000) 1.03
Trehalose: a cryoprotectant that enhances recovery and preserves function of human pancreatic islets after long-term storage. Diabetes (1997) 1.02
Sex differentials in mortality. WHO Chron (1984) 1.02
Functional beta-cell mass after transplantation of human fetal pancreatic cells: differentiation or proliferation? Diabetes (1997) 1.00
Reducing child mortality. Bull World Health Organ (2000) 0.94
Isolation and characterization of a cell line from the epithelial cells of the human fetal pancreas. Cell Transplant (1997) 0.92
Epidemiologic surveillance of the tobacco epidemic. MMWR Morb Mortal Wkly Rep (1992) 0.91
Keratinocyte growth factor and beta-cell differentiation in human fetal pancreatic endocrine precursor cells. Diabetologia (2003) 0.89
Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes (1999) 0.88
Developmental gene expression in the human fetal pancreas. Pediatr Res (1994) 0.86
Decrease in the number of neonatal islets required for successful transplantation by strict metabolic control of diabetic rats. Transplantation (1988) 0.85
Smoking and death in Russia. Tob Control (1998) 0.84
Factors influencing islet transplantation. Number, location, and metabolic control. Transplantation (1990) 0.83
A note on estimating the cause of death structure in high mortality populations. Popul Bull UN (1982) 0.83
The use of digital image processing to quantitate angiogenesis induced by basic fibroblast growth factor and transplanted pancreatic islets. Microvasc Res (1991) 0.81
Protection from cell death in cultured human fetal pancreatic cells. Cell Transplant (2000) 0.81
Tuberculosis mortality differentials in Indonesia during 2007-2008: evidence for health policy and monitoring. Int J Tuberc Lung Dis (2011) 0.80
Transplantation of human fetal pancreas: fresh vs. cultured fetal islets or ICCS. J Mol Med (Berl) (1999) 0.80
100 years of mortality due to chronic obstructive pulmonary disease in Australia: the role of tobacco consumption. Int J Tuberc Lung Dis (2012) 0.79
Enhancement of pancreatic islet cell monolayer growth by endothelial cell matrix and insulin. In Vitro Cell Dev Biol (1989) 0.79
Development of a cell line from the human fetal pancreas. Transplant Proc (1995) 0.78
Maturation and function of human fetal pancreatic cells after cryopreservation. Transplantation (1993) 0.78
Analysis of a human fetal pancreatic islet cell line. Transplant Proc (1997) 0.78
Use of hepatocyte growth factor/scatter factor to increase transplantable human fetal islet cell mass. Transplant Proc (1994) 0.77
Health for all: analyzing health status and determinants. World Health Stat Q (1998) 0.77
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci (1990) 0.77
Angiogenic peptides in pancreatic islet transplantation to diabetic rats. Transplantation (1990) 0.76
In vivo maturation and growth potential of human fetal pancreases: fresh versus cultured tissue. Transplant Proc (1995) 0.76
Investigating Australia's burden of disease. Med J Aust (2000) 0.75
Changing grassroots perception on the family. Rural Reconstr Forum (1995) 0.75
Using national mortality data to study the changing sex differential in mortality. Soz Praventivmed (1984) 0.75
Mortality patterns and trends among the elderly in developed countries. World Health Stat Q (1982) 0.75
Generation of viable isletlike cell clusters from cryopreserved human fetal pancreas. Transplant Proc (1992) 0.75
The impact of demographic trends on health: introduction. World Health Stat Q (1987) 0.75
Health projections. Introduction. World Health Stat Q (1984) 0.75
Health outlook for South and East Asia for the year 2000. World Health Stat Q (1981) 0.75
[Preventable deaths: general view]. World Health Stat Q (1989) 0.75